Literature DB >> 24127856

N-methyl-D-aspartate receptor antibody-associated movement disorder without encephalopathy.

Yael Hacohen1, Nomazulu Dlamini, Tammy Hedderly, Elaine Hughes, Martin Woods, Angela Vincent, Ming Lim.   

Abstract

N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is a well-recognized clinico-immunological syndrome that presents with a movement disorder, cognitive decline, psychiatric symptoms, and epileptic seizures. A pure monosymptomatic presentation is rare; however, some patients present predominantly with a movement disorder in the absence of encephalopathy. Here, we describe three paediatric patients with an NMDAR antibody-mediated movement disorder: a 5-year-old female with acute onset hemichorea, a 10-year-old female with generalized chorea, and a 12-year-old male with abdominal myoclonus. These patients did not develop the characteristic encephalopathy syndrome seen in NMDAR encephalitis, but all three had other associated subtle cognitive deficits. The patients demonstrated good responses to immunotherapy.
© 2013 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24127856     DOI: 10.1111/dmcn.12321

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  15 in total

1.  Partial Manifestation of Anti-NMDA-R Encephalitis with Predominant Movement Disorder.

Authors:  Vrajesh Udani; Neelu Desai; Abhijeet Botre
Journal:  Mov Disord Clin Pract       Date:  2015-09-01

Review 2.  Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia.

Authors:  Ed Needham; Michael S Zandi
Journal:  J Neurol       Date:  2014-09-03       Impact factor: 4.849

Review 3.  Autoimmune encephalopathies.

Authors:  Frank Leypoldt; Thaís Armangue; Josep Dalmau
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

4.  Childhood Anti-NMDA Receptor Encephalitis.

Authors:  Renu Suthar; Arushi Gahlot Saini; Naveen Sankhyan; Jitendra Kumar Sahu; Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2016-01-23       Impact factor: 1.967

5.  Proteomic analysis of human frontal and temporal cortex using iTRAQ-based 2D LC-MS/MS.

Authors:  Long Xu; Haidan Sun; Yang Zhang; Zhengguang Guo; Xiaoping Xiao; Xin Zhou; Kun Hu; Wei Sun; Bo Wang; Weiming Liu
Journal:  Chin Neurosurg J       Date:  2021-05-05

6.  N-methyl-D-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children.

Authors:  Sukhvir Wright; Yael Hacohen; Leslie Jacobson; Shakti Agrawal; Rajat Gupta; Sunny Philip; Martin Smith; Ming Lim; Evangeline Wassmer; Angela Vincent
Journal:  Arch Dis Child       Date:  2015-01-30       Impact factor: 3.791

7.  NMDA receptor antibodies associated with distinct white matter syndromes.

Authors:  Yael Hacohen; Michael Absoud; Cheryl Hemingway; Leslie Jacobson; Jean-Pierre Lin; Mike Pike; Sunil Pullaperuma; Ata Siddiqui; Evangeline Wassmer; Patrick Waters; Sarosh R Irani; Camilla Buckley; Angela Vincent; Ming Lim
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-04-24

8.  Variations of movement disorders in anti-N-methyl-D-aspartate receptor encephalitis: A nationwide study in Taiwan.

Authors:  Bi-Chun Duan; Wen-Chin Weng; Kuang-Lin Lin; Lee Chin Wong; Sung-Tse Li; Mei-Hsin Hsu; Jainn-Jim Lin; Pi-Chaun Fan; Ming-I Lin; Nan-Chang Chiu; Yu-Ching Lin; Huei-Shyong Wang; Kun-Long Hung; Wang-Tso Lee
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 9.  Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.

Authors:  Sarosh R Irani; Jeffrey M Gelfand; Adam Al-Diwani; Angela Vincent
Journal:  Ann Neurol       Date:  2014-07-10       Impact factor: 10.422

Review 10.  Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology.

Authors:  Bettina Balint; Angela Vincent; Hans-Michael Meinck; Sarosh R Irani; Kailash P Bhatia
Journal:  Brain       Date:  2018-01-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.